Global Allergy Immunotherapy Market Size To Grow USD 4.5 Billion By 2030 | CAGR of 9.5%

Global Allergy Immunotherapy  Market Size To Grow USD 4.5 Billion By 2030

According to a research report published by Spherical Insights & Consulting, the Global Allergy Immunotherapy Market Size to grow from USD 2.0 billion in 2021 to USD 4.5 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period. The expected rise in revenue can be traced to the growing number of allergy illnesses and the trouble they cause for people worldwide. Complex allergies that make people sicker are putting a strain on the healthcare system, driving research and development in this industry. The goal is to come up with new medicines. The rising levels of air pollution inside and outside have also been linked to a rise in the number of people with asthma and allergies that affect the respiratory system. The Asthma and Allergy Foundation of America (AAFA) says that more pollen causes more than 25 million people allergies.

Browse key industry insights spread across 240 pages with 104 market data tables and figures & charts from the report "Global Allergy Immunotherapy Market Size, Share, and COVID-19 Impact Analysis By Type of Immunotherapy (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030." in detail along with the table of contents https://www.sphericalinsights.com/reports/allergy-immunotherapy-market

The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.

The subcutaneous immunotherapy (SCIT) segment to account for the largest market size during the forecast period

 Based on the Type of Immunotherapy, the allergy immunotherapy market is categorized into Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT). The subcutaneous immunotherapy (SCIT) segment accounts for the largest market size during the forecast period. The subcutaneous immunotherapy (SCIT) method is the most common and effective way to treat allergies. The treatment works to ease the symptoms of allergic rhinitis, asthma, and being overly sensitive to insect stings. SCIT has also been useful for treating allergies to more than one type of substance. Because of this, the number of people using SCIT has grown more than those using SLIT.

The allergic rhinitis segment to hold a higher CAGR during the forecast period

 Based on the allergy type, the allergy immunotherapy market is categorized into Allergic Rhinitis, Asthma, Food Allergy, and Others. The allergic rhinitis segment to hold a higher CAGR during the forecast period. The American College of Allergy, Asthma, and Immunology says that 24 million people in the United States have asthma, and that 6 million of them are children. The numbers show that about 50 million people in the United States have some kind of allergy every year. So, it is expected that the growing number of illnesses caused by allergy diseases will give the market a chance to grow in a way that is good for business.

North America is estimated to account for the highest market share in 2021.

The Global Allergy Immunotherapy Market has been segmented into five major regions: North America, Europe, Asia-Pacific, South America, The Middle East and Africa. There are a number of reasons for the growth, such as the fact that allergic reactions are becoming more common and more people are becoming aware of the treatments that are available. For example, a report from the International Food Information Council that came out in May 2022 says that about 32.0 million people in the United States have said they have food allergies, and about 200,000 people go to the emergency room every year because of food allergies. It was also found that food allergies were common among young people. About one in every 13 children in the United States has been diagnosed with a food allergy, and about 40.0% of children with food allergies are allergic to more than one food. It is thought that events like these will make the need for allergy immunotherapy in this area grow faster. Asia-Pacific to hold a higher CAGR during the forecast period.

Major vendors in the Global Allergy Immunotherapy Market include ASIT Biotech, Circassia, Mylan N.V., Adamis Pharmaceuticals Corporation, Merck KGaA, Stallergenes Greer plc, Allergy Therapeutics, ALK-Abelló A/S, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, LETIPharma, and DBV Technologies SA.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting And Research Firm
• Venture capitalists
• Third-party knowledge providers
• Value-Added Resellers (VARs)

Recent Development

• In July 2022, Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy, released good news about the benefits of sublingual liquid allergen immunotherapy treatment (AIT) at the onset and worsening of asthma in people with allergic rhinitis (AIT).

• In March 2022, PVX108 is a type of immunotherapy from the next generation tested to treat peanut allergies. Aravax Pty Ltd. announced that they had opened an investigational new drug (IND) application for Phase 2 clinical trials of PVX108.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019.5 to 2030. Spherical Insights has segmented the global allergy immunotherapy market based on the below-mentioned segments:

Global Allergy Immunotherapy Market, By Type of Immunotherapy

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)

Global Allergy Immunotherapy Market, By Allergy Type

• Allergic Rhinitis
• Asthma
• Food Allergy
• Others

Global Allergy Immunotherapy Market, Regional Analysis

• North America
  • The US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• The Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter